Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation. The CDMO FUJIFILM Biotechnologies is in the midst of a growth upswing, with about $7 billion in expansion projects underway across the United States and Europe. The centerpiece is its $3.2 billion Holly Springs, North Carolina site , whose first phase came online in September 2025. A second phase is slated for around 2028. In Denmark, the company is expanding its Hillerød campus with another eight 20,000-liter bioreactors and two new downstream streams, and in early 2026 it opened the UK’s largest single-use…
The CDMO FUJIFILM Biotechnologies is in the midst of a growth upswing, with about $7 billion in expansion projects underway across the United States and Europe. The centerpiece is its $3.2 billion Holly Springs, North Carolina site, whose first phase came online in September 2025. A second phase is slated for around 2028. In Denmark,…
The post FUJIFILM Biotechnologies COO Maja Herold Pedersen on AI, autonomy and the path from quality to operations appeared first on Drug Discovery and Development.
US Pharma Marketing